Lantheus Medical Imaging has appointed a new chief medical officer (CMO) and a new chief science officer (CSO).
Jeffrey Humphrey, MD, is the company's new CMO. He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy. He has spent more than two decades working for pharmaceutical companies such as Bayer, Bristol-Myers Squibb, Kyowa Kirin, and Pfizer.
Jean-Claude Provost, MD, is the company's new CSO. He will support the firm's business development activities to advance and enhance the company’s pipeline and capabilities, Lantheus said.
The two appointments will take effect May 28.
